# multiomics-survival-modeling
Multi-omics survival modeling in breast cancer integrating gene expression and copy number alterations to identify paclitaxel resistanceâ€“informed prognostic genes, pathways, and a validated gene signature. Includes CoxPH, KM, RMST, time-dependent AUC, pathway scoring, network analysis, and cross-cohort validation in METABRIC and TCGA-BRCA.
